Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis Ten to 15% of patients with pouchitis experience refractory or recurrent disease. The aim of this study was to evaluate the effectiveness of a single daily... T Mimura,F Rizzello,U Hel...
The IHF fraction (16.3 ± 15.0% →14.1 ± 7.7%, p = 0.032) was decreased after 12 weeks of probiotic treatment compared to that at baseline, but was not reduced in the placebo group. The decrease in IHF (mean difference: −2.61%, p = 0.0129) was also greater ...
However, the results from recent research have supported the concept that probiotics are not equally effective [3]. Clinical trials have investigated the health benefits of many single or multi-strain probiotic mixtures to meet patients’ health needs [4]. Yet, due to the manufacturing processes, ...
We have recently documented the efficacy of a highly concentrated probiotic preparation (VSL#3) in the prevention of flare-up in patients with chronic pouc... Paolo,Gionchetti,and,... - 《Gastroenterology》 被引量: 2040发表: 2000年 Survival of lactic acid bacteria in the human stomach and ...
- 《Microbiology & Molecular Biology Reviews Mmbr》 被引量: 2621发表: 2000年 Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial We have recently documented the efficacy of a highly concentrated probiotic preparation (VSL#3) in the prevention of flare-...